At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
CGM at diagnosis of T1Ddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes
In Brief
A clinical study evaluating CGM at diagnosis of T1D for Type 1 Diabetes Mellitus. Completed, enrolled 120 participants across 2 sites.
Detailed Summary
The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
CollaboratorsUniversity of Colorado, Denver
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedApr 2016
Primary CompletionFeb 2020
TodayJul 2026
First PostedApr 12, 2016
Enrollment StartFeb 1, 2016
Primary CompletionFeb 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 10.2 years ago
Interventions
CGM at diagnosis of T1Ddevice
Initiation of non-adjunctive CGM use at diagnosis of T1D